Suresh T. Chari

50.6k total citations · 10 hit papers
432 papers, 27.6k citations indexed

About

Suresh T. Chari is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Suresh T. Chari has authored 432 papers receiving a total of 27.6k indexed citations (citations by other indexed papers that have themselves been cited), including 259 papers in Surgery, 196 papers in Oncology and 111 papers in Epidemiology. Recurrent topics in Suresh T. Chari's work include Pancreatitis Pathology and Treatment (195 papers), Pancreatic and Hepatic Oncology Research (190 papers) and IgG4-Related and Inflammatory Diseases (98 papers). Suresh T. Chari is often cited by papers focused on Pancreatitis Pathology and Treatment (195 papers), Pancreatic and Hepatic Oncology Research (190 papers) and IgG4-Related and Inflammatory Diseases (98 papers). Suresh T. Chari collaborates with scholars based in United States, India and Japan. Suresh T. Chari's co-authors include Thomas C. Smyrk, Naoki Takahashi, Gloria M. Petersen, Randall K. Pearson, Bret T. Petersen, Jonathan E. Clain, Mark Topazian, Lizhi Zhang, Massimo Falconi and Masao Tanaka and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Suresh T. Chari

412 papers receiving 26.7k citations

Hit Papers

International consensus g... 2005 2026 2012 2019 2012 2005 2011 2006 2008 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
    2012 1.5k citations Suresh T. Chari et al. Pancreatology profile →
  2. International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas
    2005 1.5k citations Suresh T. Chari et al. Pancreatology profile →
  3. International Consensus Diagnostic Criteria for Autoimmune Pancreatitis
    2011 989 citations Suresh T. Chari, Luca Frulloni et al. Pancreas profile →
  4. Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience
    2006 686 citations Suresh T. Chari, Thomas C. Smyrk et al. Clinical Gastroenterology and Hepatology profile →
  5. Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy
    2008 595 citations Suresh T. Chari, Lizhi Zhang et al. profile →
  6. Early Detection of Pancreatic Cancer: Opportunities and Challenges
    2019 517 citations Suresh T. Chari et al. profile →
  7. Rituximab for IgG4-related disease: a prospective, open-label trial
    2015 444 citations Mark Topazian, Thomas C. Smyrk et al. profile →
  8. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease
    2019 409 citations Suresh T. Chari, Dai Inoue et al. profile →
  9. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
    2016 337 citations Phil A. Hart, Dana K. Andersen et al. profile →
  10. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer
    2017 324 citations Dana K. Andersen, Murray Korc et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suresh T. Chari United States 84 18.5k 13.4k 9.2k 9.1k 4.8k 432 27.6k
Thomas C. Smyrk United States 90 15.0k 0.8× 9.7k 0.7× 8.1k 0.9× 7.2k 0.8× 4.2k 0.9× 449 28.4k
Mari Mino–Kenudson United States 80 8.4k 0.5× 13.8k 1.0× 1.7k 0.2× 4.0k 0.4× 5.5k 1.2× 423 24.4k
Massimo Falconi Italy 81 13.7k 0.7× 26.5k 2.0× 1.0k 0.1× 16.1k 1.8× 2.4k 0.5× 662 31.4k
Mahul B. Amin United States 79 9.6k 0.5× 5.8k 0.4× 3.6k 0.4× 1.3k 0.1× 7.5k 1.6× 346 27.3k
Rodolfo Montironi Italy 77 10.3k 0.6× 5.9k 0.4× 4.3k 0.5× 1.5k 0.2× 9.7k 2.0× 877 30.3k
George D. Demetri United States 93 8.9k 0.5× 11.1k 0.8× 3.2k 0.3× 1.3k 0.1× 6.6k 1.4× 346 38.0k
Joaquim Bellmunt United States 77 15.7k 0.8× 13.6k 1.0× 1.1k 0.1× 1.4k 0.2× 5.9k 1.2× 651 30.8k
Heikki Joensuu Finland 97 7.1k 0.4× 12.8k 1.0× 1.5k 0.2× 1.6k 0.2× 8.4k 1.7× 583 35.5k
David G. Bostwick United States 90 5.7k 0.3× 3.7k 0.3× 6.2k 0.7× 1.1k 0.1× 6.6k 1.4× 458 27.2k
John C. Cheville United States 82 7.9k 0.4× 7.5k 0.6× 1.5k 0.2× 1.6k 0.2× 12.5k 2.6× 511 27.6k

Countries citing papers authored by Suresh T. Chari

Since Specialization
Citations

This map shows the geographic impact of Suresh T. Chari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh T. Chari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh T. Chari more than expected).

Fields of papers citing papers by Suresh T. Chari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh T. Chari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh T. Chari. The network helps show where Suresh T. Chari may publish in the future.

Co-authorship network of co-authors of Suresh T. Chari

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh T. Chari. A scholar is included among the top collaborators of Suresh T. Chari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh T. Chari. Suresh T. Chari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenzweig, Allison, Jordan Berlin, Suresh T. Chari, et al.. (2023). Management of Patients With Pancreatic Cancer Using the “Right Track” Model. The Oncologist. 28(7). 584–595. 10 indexed citations
2.
Majumder, Shounak, William R. Taylor, Patrick H. Foote, et al.. (2021). High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9. Clinical Cancer Research. 27(9). 2523–2532. 34 indexed citations
3.
Mačinga, Peter, Lukáš Bajer, Marco Del Chiaro, et al.. (2021). Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review. Pancreatology. 21(5). 928–937. 16 indexed citations
4.
Chari, Suresh T., Anirban Maitra, Lynn M. Matrisian, et al.. (2021). Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma. Contemporary Clinical Trials. 113. 106659–106659. 31 indexed citations
5.
Hori, Yasuki, Suresh T. Chari, Yoshihisa Tsuji, et al.. (2021). Diagnosing Biliary Strictures. SHILAP Revista de lepidopterología. 5(3). 535–541. 9 indexed citations
6.
Marya, Neil B., Suresh T. Chari, Ferga C. Gleeson, et al.. (2020). Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis. Gut. 70(7). 1335–1344. 106 indexed citations
7.
Mohapatra, Sonmoon, Paris Charilaou, Ayush Sharma, et al.. (2019). Significance of peripheral eosinophilia for diagnosis of IgG4-related disease in subjects with elevated serum IgG4 levels. Pancreatology. 20(1). 74–78. 7 indexed citations
8.
Gupta, Madhur, et al.. (2018). Correlation Between Insulin Resistance and Homocysteine in Hypothyroid Patients. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Abbruzzese, James L., Dana K. Andersen, Carl Borrebaeck, et al.. (2018). The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities. Pancreas. 47(5). 516–525. 44 indexed citations
10.
Chari, Suresh T., et al.. (2017). Use of mini-CEX as a teaching learning method in physiology for undergraduate medical students. National Journal of Physiology Pharmacy and Pharmacology. 7(4). 1–1. 7 indexed citations
11.
Pitale, Shailesh, et al.. (2017). Study of vitamin D levels and its correlation with insulin resistance. National Journal of Physiology Pharmacy and Pharmacology. 7(9). 1–1. 4 indexed citations
12.
Chari, Suresh T.. (2016). Defining chronic pancreatitis. Pancreatology. 16(5). 694–695. 4 indexed citations
13.
Kenner, Barbara, Suresh T. Chari, Anirban Maitra, et al.. (2016). Early Detection of Pancreatic Cancer—a Defined Future Using Lessons From Other Cancers. Pancreas. 45(8). 1073–1079. 50 indexed citations
14.
Javeed, Naureen, Gunisha Sagar, Shamit K. Dutta, et al.. (2014). Pancreatic Cancer–Derived Exosomes Cause Paraneoplastic β-cell Dysfunction. Clinical Cancer Research. 21(7). 1722–1733. 150 indexed citations
15.
Balasubramanian, Gokulakrishnan, Aravind Sugumar, Thomas C. Smyrk, et al.. (2012). Demystifying seronegative autoimmune pancreatitis. Pancreatology. 12(4). 289–294. 13 indexed citations
16.
Gupta, Madhur, et al.. (2011). Dyslipidemia and oxidative stress in patients of psoriasis.. OpenMETU (Middle East Technical University). 22(2). 0. 29 indexed citations
17.
Sah, Raghuwansh P., Rahul Pannala, Suresh T. Chari, et al.. (2009). Prevalence, Diagnosis, and Profile of Autoimmune Pancreatitis Presenting with Features of Acute or Chronic Pancreatitis. Clinical Gastroenterology and Hepatology. 8(1). 91–96. 46 indexed citations
18.
Muders, Michael H., Shamit K. Dutta, Ling Wang, et al.. (2006). Expression and Regulatory Role of GAIP-Interacting Protein GIPC in Pancreatic Adenocarcinoma. Cancer Research. 66(21). 10264–10268. 37 indexed citations
19.
Lévy, Michaël, M Wiersema, & Suresh T. Chari. (2006). Chronic pancreatitis: Focal pancreatitis or cancer? Is there a role for FNA/biopsy? Autoimmune pancreatitis. Endoscopy. 38(S 1). 30–35. 64 indexed citations
20.
Chari, Suresh T., et al.. (1999). Towards sound approaches to counteract power-analysis attacks. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas C. Smyrk Breakdown of academic impact, for papers by Mari Mino–Kenudson Breakdown of academic impact, for papers by Massimo Falconi Breakdown of academic impact, for papers by Mahul B. Amin Breakdown of academic impact, for papers by Rodolfo Montironi Breakdown of academic impact, for papers by George D. Demetri Breakdown of academic impact, for papers by Joaquim Bellmunt Breakdown of academic impact, for papers by Heikki Joensuu Breakdown of academic impact, for papers by David G. Bostwick Breakdown of academic impact, for papers by John C. Cheville
Rankless by CCL
2026